We’ve issued a new funding opportunity announcement (FOA): Exploring the Scientific Value of Existing or New Sepsis Human Biospecimen Collections (R21/R33 – Clinical Trial Not Allowed) (PAR-21-077). This FOA aims to promote the optimal use, testing, and sharing of patient-derived materials. It stems from recommendations of the NAGMSC working group on sepsis and input from the scientific community for strategies to rebalance NIGMS’ investment in sepsis research.
Continue reading “Funding Opportunity: R21/R33 to Test Existing or New Biospecimens from Sepsis Patients”Funding Opportunity: R21/R33 to Test Existing or New Biospecimens from Sepsis Patients
0 comments